Aurobindo Pharma Limited
AUROPHARMA
株式のランク
#2074
Aurobindo Pharma Limited, a biopharmaceutical company, develops, manufactures,... Aurobindo Pharma Limited, a biopharmaceutical company, develops, manufactures, commercializes, and sells generic pharmaceuticals, active pharmaceutical ingredients (APIs), and injectables. The company offers formulation in form of oral solids, liquids, injectables, vaccines, and metered dose inhalers; and APIs, biosimilars, and peptides targeting therapeutic areas, such as central nervous system, cardiovascular, respiratory, antibiotics, anti-retroviral, anti-diabetics, gastroenterology, oncology, and dermatology. It also provides antiretroviral drugs for the people and children living with HIV; and API space for sterile and non-sterile penicillin’s, cephalosporins, penems, and non-beta lactams. The company has operations in India, the United States, Europe, Puerto Rico, and internationally. The company was incorporated in 1986 and is headquartered in Hyderabad, India.
株価
$17.34
時価総額
$9.98B
変化（1日）
-3.08%
変化（1年）
38.71%
国
IN
取引 Aurobindo Pharma Limited (AUROPHARMA)
カテゴリー
Healthcare
Aurobindo Pharma Limited（AUROPHARMA）の利益
Jun 2026 時点の利益 TTM: $598.16M
Aurobindo Pharma Limited の最新の財務報告によると、同社の現在の利益は $598.16M です。2024 年には $525.28M の利益を上げ、これは 2023 年の利益 $317.90M と 増加 です。このページに表示されている利益は、利息および税引き前利益、すなわち EBIT です。
Aurobindo Pharma Limited の利益の推移（2004 〜 2026）
各年末の利益
| 年 | 利益 | 変化 |
|---|---|---|
| 2026 (TTM) | $598.16M | 0.98% |
| 2025 | $592.37M | 12.77% |
| 2024 | $525.28M | 65.24% |
| 2023 | $317.90M | -28.45% |
| 2022 | $444.31M | -55.71% |
| 2021 | $1.00B | 101.91% |
| 2020 | $496.85M | 11.61% |
| 2019 | $445.18M | -10.57% |
| 2018 | $497.80M | 5.47% |
| 2017 | $471.99M | 13.94% |
| 2016 | $414.23M | 19.23% |
| 2015 | $347.42M | -3.94% |
| 2014 | $361.67M | 425.28% |
| 2013 | $68.85M | -263.95% |
| 2012 | $-42.00M | -123.75% |
| 2011 | $176.86M | 5.59% |
| 2010 | $167.49M | 1,070.92% |
| 2009 | $14.30M | -80.38% |
| 2008 | $72.91M | 53.10% |
| 2007 | $47.62M | 115.32% |
| 2006 | $22.12M | 427.99% |
| 2005 | $4.19M | -88.08% |
| 2004 | $35.14M | 0.00% |
同業他社の利益
| 企業 | 利益 | 利益の差 | 国 |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $1.76B | 195.00% |
IN
|
